检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]攀枝花市中心医院呼吸内科,四川攀枝花617000
出 处:《临床肺科杂志》2016年第6期988-991,共4页Journal of Clinical Pulmonary Medicine
摘 要:目的研究内科胸腔镜在渗出性胸腔积液检查中的高效性、安全性、并发症。方法 2013年12月至2015年8月128例渗出性胸腔积液患者,随机分为A组、B组,各组64例。A组胸腔积液行常规检查,B组行内科胸腔镜检查。结果 A组:36例为结核性,24例为恶性,3例为炎性或脓胸,1例患者病因不明确,5例患者需手术诊断。B组:40例为结核性,21例为恶性,3例炎性或脓胸,3例需手术诊断。恶性肿瘤患者45名(35.2%,P<0.01),结核性胸膜炎患者76人(59.4%),炎性或脓胸患者6人(4.7%),1人病因不明确(0.7%)。其中腺癌占28例,鳞癌5例,小细胞癌9例,恶性间皮瘤3例。内科胸腔镜并发症较少(7%,P<0.05)。结论内科胸腔积液诊断尤其针对反复或持续性胸腔积液患者,是一种高效、微创、安全的检查手段。Objective To study the efficiency, safety and complication of medical thoracoscope in effusion hydrothorax. Methods 128 patients with pleural effusion from December 2013 to August 2015 were randomly divid-ed into two groups. The group A was given routine examination, and the group B was performed by medical thoraco-scope. Results In the group A, there were 36 cases of tuberculous, 24 cases of malignant, 3 cases inflammatory or empyema, 1 case without clear etiology, and 5 cases needed to surgical diagnosis. In the group B, there were 40 ca-ses of tuberculosis, 21 cases were malignant, 3 cases of inflammatory or empyema, and 3 cases needed operation di-agnosis. There were 45 patients with malignant tumor ( 35. 2%, P〈0. 01 ) , 76 patients with tuberculous pleurisy (59. 4%), 6 patients inflammatory or empyema (4. 7%), and 1 case without clear causes (0. 7%). Among them, there were 28 cases of adenocarcinoma, 5 cases of squamous cell carcinoma, 9 cases of small cell carcinoma, and 3 cases of malignant mesothelioma. The incidence of department of internal medicine complications was lower (7%, P〈0. 05). Conclusion It is an effective, minimally invasive and safe method for the diagnosis of pleural effusion by medical thoracoscope, especially for patients with recurrent or persistent pleural effusion.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.21